Diazepam

  • Description and indication for use

    Diazepam is a minor tranquiliser of the benzodiazepine class.  It has sedative, muscle relaxant, anticonvulsant and amnesic properties.  It is a CNS depressant which acts on the limbic system, thalamus and hypothalamus.

    It is used as a sedative for agitated, restless infants who are ventilated and as an anticonvulsant when indicated.

    Dose

    IV: 

    0.1 to 0.3 mg/kg/dose stat.  Dose repeated as ordered (can be repeated 4 hourly/PRN).

    Reconstitution/Dilution

    Ampoule = 10 mg in 2 mL (5 mg/mL).

    IV:    

    Withdraw 0.2 mL of 5 mg/mL solution and add to 4.8 mL of sodium chloride 0.9% in a 5 mL syringe = 0.2 mg/mL. (Ensure solution is not cloudy – otherwise dilute further).

    Discard excess volume to obtain required dose or withdraw dose using another syringe.

    Route and method of administration

    IM:   

    Not recommended in neonates.

    IV:    

    Give slowly over 5 minutes.  Flush line with sodium chloride 0.9% before and after.

    Solution for injection should be FRESHLY PREPARED.

    Side effects

    Respiratory depression.

    CNS depression, drowsiness.

    Hypotension.

    Hypo/hyperthermia.

    Pain and phlebitis at the injection site.

    Special precautions

    Caution when also using other anticonvulsants or CNS depressants.

    Caution in patients with hepatic and renal impairment.

    Contraindications

    Shock.

    Compatible Solutions

    Diazepam is relatively insoluble in almost all solutions.

    Sodium Chloride 0.9% and Glucose 5% may be used to dilute the 5 mg/mL solution, but it must be at least diluted as above.

    Incompatibilities

    Administer alone or contact pharmacy for further information.

    Precipitate forms when mixed with almost all other drugs.

    Drug interactions

    Phenobarbitone Additive CNS and respiratory depression, may cause apnoea and hypoventilation.
    Digoxin May cause plasma Digoxin levels to increase.

    Nursing responsibilities

    Observe infant carefully for signs of respiratory depression.

    Cardiorespiratory monitor.

    Monitor BP.

    Do not administer cloudy solution.

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for